venBio biotechnology firm tweaks top ranks as flagship soars 50.3% in 2014

By Simone Foxman

Thu Aug 7, 2014


Two years of outperformance push firm assets to $335 million.


Biotech-focused venBio Select Advisor is off to another jaw-dropping year and has been formalizing its infrastructure to accommodate rapid growth. The now-$335 million firm has hired a chief financial and compliance officer, and it put a sole portfolio manager in charge of the high-flying flagship hedge fund.

That hedge fund, the venBio Select Fund, generated a return of 50.3% through July, according to a July 31 investor letter. That compares with a rise of 4.50% for the Absolute Return Global Equity Index. The fund's assets have more than tripled in that time period, from $44 million at yearend 2013, to $137 million as of July 31 (firmwide assets of $335 million also include a separate private equity fund). The hedge fund began 2013 with less than $20 million and went on to return 122.43%....

ISSN: 2151-1845 / CDC10004H

TAKE A FREE TRIAL

The full contents of this article are available to Absolute Return subscribers and trialists only.

To continue reading please, take a free trial, subscribe or log in.


Subscribe

Subscribers have unlimited access to all current and archive content. Start your subscription today - click on the button below.

Subscribe now